Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Torrent's Nebivolol vs Bystolic in Healthy Subjects
NCT03517020Phase 1Completed
- Sponsor
- Torrent Pharmaceuticals Limited
- Start
- Apr 2011
- Primary completion
- Jun 2011
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of nebivolol in hypertension (HTN) (2 arms), sponsored by Torrent Pharmaceuticals Limited. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve. Started Apr 2011; status: completed.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03517020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03517020.